A post hoc sensitivity analysis of survival probabilities in a multinational phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia.

A post hoc sensitivity analysis of survival probabilities in a multinational phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2014 Feb; 14(1):68-72.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Azacitidine
Drug Administration Schedule
Female
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Prognosis
Treatment Outcome

authors with profiles

HAGOP M KANTARJIAN